Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
Allarity Therapeutics Inc (NASDAQ: ALLR) closed the day trading at $1.54 up 2.67% from the previous closing price of $1.5. In other words, the price has increased by $2.67 from its previous closing price. On the day, 2.53 million shares were traded. ALLR stock price reached its highest trading level at $1.7 during the session, while it also had its lowest trading level at $1.48.
Ratios:
For a better understanding of ALLR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.31 and its Current Ratio is at 2.31. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Ascendiant Capital Markets on July 28, 2025, initiated with a Buy rating and assigned the stock a target price of $9.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ALLR now has a Market Capitalization of 22514184 and an Enterprise Value of 6088239.
Stock Price History:
The Beta on a monthly basis for ALLR is 0.19, which has changed by -0.6944444 over the last 52 weeks, in comparison to a change of 0.16844666 over the same period for the S&P500. Over the past 52 weeks, ALLR has reached a high of $5.94, while it has fallen to a 52-week low of $0.61. The 50-Day Moving Average of the stock is 48.22%, while the 200-Day Moving Average is calculated to be 49.55%.
Shares Statistics:
Over the past 3-months, ALLR traded about 6.81M shares per day on average, while over the past 10 days, ALLR traded about 41408430 shares per day. A total of 14.62M shares are outstanding, with a floating share count of 11.17M. Insiders hold about 23.57% of the company’s shares, while institutions hold 1.33% stake in the company. Shares short for ALLR as of 1755216000 were 526966 with a Short Ratio of 0.08, compared to 1752537600 on 706855. Therefore, it implies a Short% of Shares Outstanding of 526966 and a Short% of Float of 3.5999999999999996.
Earnings Estimates
At present, 1.0 analysts are actively evaluating the performance of Allarity Therapeutics Inc (ALLR) in the stock market.The consensus estimate for the next quarter is -$0.21, with high estimates of -$0.21 and low estimates of -$0.21.
Analysts are recommending an EPS of between -$0.88 and -$0.88 for the fiscal current year, implying an average EPS of -$0.88. EPS for the following year is -$0.83, with 1.0 analysts recommending between -$0.83 and -$0.83.
